<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="336693">
  <stage>Registered</stage>
  <submitdate>4/04/2011</submitdate>
  <approvaldate>13/04/2011</approvaldate>
  <actrnumber>ACTRN12611000380998</actrnumber>
  <trial_identification>
    <studytitle>Do children between 1 and 6 years suffering from recurrent acute otitis media benefit from treatment with grommets.</studytitle>
    <scientifictitle>The effect of ventilation tubes on recurrent acute otitis media in children 1-6 years.</scientifictitle>
    <utrn>U1111-1120-2371</utrn>
    <trialacronym>NOROS</trialacronym>
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Recurrent acute otitis media</healthcondition>
    <conditioncode>
      <conditioncode1>Ear</conditioncode1>
      <conditioncode2>Other ear disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Insertion of ventilation tubes. Placing in the eardrum a grommet to ventilate the middle ear space. Administered under general anaesthetics. Duration 15 minutes.</interventions>
    <comparator>Standard care. Participants are offered antibiotics if they are diagnosed with acute otitis media.</comparator>
    <control>Active</control>
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Number of middle ear infections. Diagnosed by ENT-doctor at check-up if there is a suspected infection.</outcome>
      <timepoint>1 year after inclusion</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Ear related quality of life measured with OM-6 and OMO-22</outcome>
      <timepoint>At regular intervals within 1 year (baseline, 3, 6, 9 and 12 months after inclusion)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Structural changes in the tympanic membrane. Clinical evaluation by ENT-doctor. Check list used.</outcome>
      <timepoint>The structure of the ear drum is evaluated at regular intervals (baseline, 3, 6, 9, 12 months)</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Duration of ventilation tubes</outcome>
      <timepoint>Up to 1 year</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Unwanted effects of ventilation tube insertion. Longstanding drainage, granulation tissue, persistent perforation after ventilation tube etc.) Clinical evaluation by ENT-doctor.</outcome>
      <timepoint>At regular intervals within 1 year (baseline, 3, 6, 9, 12 months or if infection is suspected)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>4 episodes of acute otitis media during the last year or 3 episodes during the last 6 months; Childs caregivers must speak fluent english or norwegian</inclusivecriteria>
    <inclusiveminage>1</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>6</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Previous treatment with ventilation tubes; previous adenoidectomy or tonsillectomy; plans to move from district within follw-up time</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Central telephone or computer randomisation system</concealment>
    <sequence>Simple randomisation by computer generated random numbers</sequence>
    <masking>Open (masking not used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>14/04/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>200</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Akershus</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Ostfold</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Hedmark</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Oppland</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Buskerud</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Vestfold</state>
    </countryoutsideaustralia>
    <countryoutsideaustralia>
      <country>Norway</country>
      <state>Oslo</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Akershus University Hospital</primarysponsorname>
    <primarysponsoraddress>Sykehusvn. 27
N-1478</primarysponsoraddress>
    <primarysponsorcountry>Norway</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Akershus University Hospital</fundingname>
      <fundingaddress>Sykehusvn. 27
N-1478</fundingaddress>
      <fundingcountry>Norway</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Peder Aabel</sponsorname>
      <sponsoraddress>Akershus University Hospital
Sykehusvn. 27
N-1478</sponsoraddress>
      <sponsorcountry>Norway</sponsorcountry>
    </secondarysponsor>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>Magnus von Unge</sponsorname>
      <sponsoraddress>Akershus University Hospital
Sykehusvn. 27
N-1478</sponsoraddress>
      <sponsorcountry>Norway</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>We want to find out if insertion of ventilation tubes reduces the number of ear infections, if the childs qaulity of life improves, and if the potential benefit of ventilation tube insertion outweighs the risks</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>The South-East Regional Committee for Medical and Health Research Ethics</ethicname>
      <ethicaddress>Postboks 1130 Blindern
N-0318 Oslo</ethicaddress>
      <ethicapprovaldate>1/11/2010</ethicapprovaldate>
      <hrec>2010/2600-1</hrec>
      <ethicsubmitdate />
      <ethiccountry>Norway</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Magnus von Unge</name>
      <address>Akershus University Hospital
Sykehusvn. 27
N-1478 Lorenskog</address>
      <phone>+47 02900</phone>
      <fax />
      <email>magus.von.unge@ahus.no</email>
      <country>Norway</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Peder Aabel</name>
      <address>Akershus University Hospital
Sykehusvn. 27
N-1478 Lorenskog</address>
      <phone>+47 02900</phone>
      <fax />
      <email>peder.aabel@ahus.no</email>
      <country>Norway</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Peder Aabel</name>
      <address>Akershus University Hospital
Sykehusvn. 27
N-1478 Lorenskog</address>
      <phone>+47 02900</phone>
      <fax />
      <email>peder.aabel@ahus.no</email>
      <country>Norway</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>